|
Wednesday, November 15, 2023
Print Current Day:
 |
|
| SESSION 23 SCHEDULE | |
|
Wednesday
SESSION 23:
GENERALITIES IN THE ENDOVASCULAR AND OPEN TREATMENT OF LOWER EXTREMITY OCCLUSIVE DISEASE AND CLTI
|
|
| x | |
| 6:40 AM - 6:45 AM | How Do Prior Endovascular Interventions Affect Future Lower Extremity Bypass Outcomes For CLTI: Why Do The Results Of The BEST-CLI Trial Make This More Important |
|
Presenter(s):Matthew T. Menard, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 6:46 AM - 6:51 AM | Do Diabetic Patients With CLTI And Extensive Foot Necrosis Have Time For An Endovascular First Strategy: Primary Open Bypass Is Better Treatment In This Setting |
|
Presenter(s):Katariina M. Noronen, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 6:52 AM - 6:57 AM | Presenting Symptoms Of Lower Extremity Occlusive Disease And Intermittent Claudication Are Different In Women Than In Men: Why Is This Important |
|
Presenter(s):Linda M. Harris, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 6:58 AM - 7:03 AM | Selective Coronary Revascularization Based On Preop CT Fractional Flow Reserve (FFRCT) Improves Long-Term Survival Of CLTI Patients After Lower Extremity Revascularization: When Should Coronary Revascularization Be Performed – Before Or After The Lower Extremity Procedure |
|
Presenter(s):Christopher K. Zarins, MD / Dainis K. Krievins, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 7:04 AM - 7:09 AM | Why Does Medial Artery Calcification (MAC) Lead To Small Artery Disease (SAD): A Computational Based Analysis Of Lower Limb Blood Flow Reveals That Increasing Vascular Stiffness May Be Causative: Can Anything Be Done About It |
|
Presenter(s):Roberto Ferraresi, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| OPTIMAL TECHNIQUES FOR VESSEL PREP FOR ENDOVASCULAR TREATMENTS | |
| 7:10 AM - 7:15 AM | Optimal Different Techniques Of Vessel Prep For Plain Old Balloon Angioplasty (POBA), Drug Coated Balloon (DCB) Treatment And Drug Eluting Stent (DES) Treatment |
|
Presenter(s):Fabrizio Fanelli, MD, EBIR Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 7:16 AM - 7:21 AM | Technical Tips For Vessel Prep For DCBs And DESs: It Is Different And Not Simple: Is Vessel Prep Currently Overrated |
|
Presenter(s):Erwin Blessing, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 7:22 AM - 7:27 AM | New Devices And A New Paradigm For Treating Lower Extremity Arterial Lesions Via A Radial Approach: Can Lesions Below The Knee Be Treated |
|
Presenter(s):Craig M. Walker, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 7:28 AM - 7:33 AM | What Are The Downsides To Trans-Radial Or Pedal Access |
|
Presenter(s):Gary M. Ansel, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| TECHNICAL TIPS ON GUIDEWIRE CHOICE AND USAGE | |
| 7:34 AM - 7:39 AM | Tips For Treating Difficult BTK/BTA Lesions: How To Get A Guidewire Across A Long Calcified Occlusion, Getting A Resistant Balloon To Go Over The Wire And Tips For Retrograde Access |
|
Presenter(s):Marco G. Manzi, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 7:40 AM - 7:45 AM | Guidewire Tips For Treating Lesions Below The Ankle (BTA): Sliding, Piercing, Dissecting, Retrograde Maneuvers |
|
Presenter(s):Roberto Ferraresi, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 7:46 AM - 7:53 AM | Panel Discussion |
| END OF SESSION 23 | |
| SESSION 24 SCHEDULE | |
|
Wednesday
SESSION 24:
NEW DEVELOPMENTS IN ATHERECTOMY, STENTS (UNCOATED, COATED AND BIORESORBABLE)
|
|
| x | |
| PROGRESS IN ATHERECTOMY | |
| 7:53 AM - 7:58 AM Power Point Presentation with Synched Audio |
New Developments In Laser Atherectomy And Lithotripsy: What Progress Has Been Made And Are Their Benefits Proven |
|
Presenter(s):George L. Adams, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 7:59 AM - 8:04 AM | Which Vascular Specialists Are Performing Tibial Atherectomies And Angioplasties For Intermittent Claudication And Are There Suboptimal Outcomes |
|
Presenter(s):Caitlin W. Hicks, MD, MS Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 8:05 AM - 8:10 AM | Update On Optical Coherence Tomography (OCT) Guided Intraluminal Crossing Catheters (Avinger) For SFA Occlusions: Intraluminal Patency Superiority And New Data On The TigerEye Catheter |
|
Presenter(s):Todd R. Vogel, MD, MPH Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 8:11 AM - 8:16 AM | 2-Year Experience With The Rotarex Atherectomy And Thrombectomy System (From BD) For Arterial Occlusive Disease And In Stent Restenosis (ISR): How Does It Work And Advantages |
|
Presenter(s):Michael K.W. Lichtenberg, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| UPDATE ON THE SUPERA STENT | |
| 8:17 AM - 8:23 AM Power Point Presentation with Synched Audio |
Update On The Advantages Of The Supera Vasculomimetic (VMI) Stent For Treating Long Complex Fempop Occlusive Lesions: Is There Value To DCB Vessel Prep First |
|
Presenter(s):Peter C.J. Goverde, MD Location: Grand Ballroom East, 3rd Floor |
|
| 8:24 AM - 8:29 AM | Update On The Supera Interwoven Stent: When Is It The Best Treatment And How To Optimally Deploy This Unique Stent |
|
Presenter(s):D. Christopher Metzger, MD / Craig M. Walker, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| DRUG ELUTING STENTS (DESs) FOR BTK LESIONS | |
| 8:30 AM - 8:35 AM | Updated Experience With Everolimus And Other Nonabsorbable DESs To Treat Infrapopliteal BTK Lesions – Long And Short - Causing CLTI: What Are The Stents And How Are They Doing |
|
Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 8:36 AM - 8:41 AM | Update On Bioresorbable Everolimus DESs To Treat BTK Lesions Causing CLTI: Promising Results Up To 5 Years: From The DISAPEAR Registry And A Meta-Analysis Of Other Bioresorbable BTK Stent Results |
|
Presenter(s):Steven Kum, MD / Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 8:42 AM - 8:47 AM | Progress In And 1-Year Results Of The LIFE-BTK Randomized Controlled Comparison Of Abbott’s Esprit Drug-Eluting Resorbable Stent With Plain Balloon Angioplasty (POBA) |
|
Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) / Sahil A. Parikh, MD / Brian G. DeRubertis, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 8:48 AM - 8:53 AM | Updated Results With A 3-French Compatible Microstent (From Micro Medical) For Antegrade Or Retrograde Insertion To Treat Tibial Artery Lesions: From The STAND RCT And The HEAL Registry |
|
Presenter(s):Robert E. Beasley, MD, FSIR, FSCAI / Marco G. Manzi, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 8:54 AM - 9:00 AM | Panel Discussion |
| END OF SESSION 24 | |
| SESSION 25 SCHEDULE | |
|
Wednesday
SESSION 25:
LOWER EXTREMITY TOPICS RELATED TO DRUG COATED BALLOONS (DCBs) AND DRUG ELUTING STENTS (DESs)
|
|
| x | |
| 9:00 AM - 9:05 AM | Older And More Recent Meta-Analyses Reveal Increased Mortality And Amputation Rates In Patients Receiving Paclitaxel Coated Devices Compared To Uncoated Devices: Are These Increased Rates Still Valid In View Of The Many Recent Studies That Do Not Confirm Them |
|
Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 9:06 AM - 9:11 AM | Large Population Based German Multicenter Study Of Paclitaxel Coated BTK DCBs And DESs Indicates Decreased Mortality And Amputation Rates Compared To Uncoated Devices |
|
Presenter(s):Christian A. Behrendt, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 9:12 AM - 9:17 AM | The Final Word On The Safety Of Paclitaxel Coated Balloons And Stents: Putting Together Observation, Randomized Trial And Meta-Analysis Derived Data |
|
Presenter(s):Eric A. Secemsky, MD, MSc / Peter A. Schneider, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 9:18 AM - 9:23 AM | 2-Year Results With The Sundance DCB (Surmodics) To Treat BTK Occlusive Lesions: From The SWING Trial |
|
Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 9:24 AM - 9:29 AM | Update On DCBs For BTK Angioplasty: RCT Comparing A Paclitaxel DCB (Litos From Acotec) Versus A Sirolimus DCB (Magic Touch From Concept Medical): Rationale Of The Studies, Update On Enrollment And Interesting Cases In The DEBATE BTK DUELL RCT |
|
Presenter(s):Francesco Liistro, MD / Edward T. Choke, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 9:30 AM - 9:35 AM | Progress With A Sustained Release Sirolimus DCB: Results With The Magic Touch DCB Compared To A Paclitaxel DCB: From The SIRONA Study |
|
Presenter(s):Thomas Zeller, MD / Andrej Schmidt, MD / Dierk Scheinert, MD / Marianne Brodmann, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 9:36 AM - 9:41 AM | Adventitial Drug Delivery With The BullFrog Device (From Mercator Medical) And The Spur Device (From Reflow): How Do They Work And How Will We Know They Improve Results |
|
Presenter(s):William A. Gray, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 9:42 AM - 9:47 AM | The Light And Darkness Of Fluoropolymer-Based Limus DESs In The Treatment Of Femoropopliteal Lesions |
|
Presenter(s):Osamu Iida, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 9:48 AM - 9:53 AM | Lower Extremity Endovascular Treatments: Who Is Performing Most Of Them And Where: Are They Overutilized And Why: How To Fix The Problem |
|
Presenter(s):Russell H. Samson, MD, DFSVS, RVT, FACS Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 9:54 AM - 9:59 AM | Are DESs Ever Associated With Aneurysmal Degeneration: Is It Related To The Drug (Paclitaxel Or Limus) Or To The Fluoropolymer Excipient To Which The Drug Is Attached |
|
Presenter(s):Osamu Iida, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 10:00 AM - 10:08 AM | Panel Discussion |
| 10:08 AM - 10:18 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 25 | |
| SESSION 26 SCHEDULE | |
|
Wednesday
SESSION 26:
NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs) AND DRUG ELUTING STENTS (DESs): UPDATES ON RANDOMIZED CONTROLLED TRIALS (RCTs) AND BTK LESION TREATMENTS WITH DCBs AND DESs
|
|
| x | |
| NEW INFORMATION ON DCBs AND DESs FOR FEMPOP LESIONS: UPDATES ON RCTs | |
| 10:18 AM - 10:23 AM | DCB Treatment Of Femoropopliteal Lesions Causing CLTI (From Boston Scientific) Is Cost Effective: Based On A 5-Year Study Of Patients In Mexico Treated With Ranger DCBs |
|
Presenter(s):Ignacio Escotto, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 10:24 AM - 10:29 AM | Stellarex (Philips) DCBs With Low Dose Paclitaxel Is Safe And Has Higher Patency Rates Than POBA With De Novo Or Recurrent Fempop Lesions At 5 Years In The ILLUMENATE US And European RCTs |
|
Presenter(s):Sean P. Lyden, MD / Marianne Brodmann, MD / Sahil A. Parikh, MD / William A. Gray, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 10:30 AM - 10:35 AM | 3-Year Results Of A RCT Comparing SurVeil DCBs (Surmodics) With In.Pact DCBs (Medtronic) For Treating Fempop Lesions: From the TRANSCEND Trial |
|
Presenter(s):Peter A. Schneider, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 10:36 AM - 10:41 AM | New Findings From The DRASTICO Study Comparing DESs To DCBs For Fempop Lesions: 5-Year Results With TASC A/B Lesions Versus TASC C/D Lesions |
|
Presenter(s):Francesco Liistro, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 10:42 AM - 10:47 AM | Value Of In.Pact DCBs (Medtronic) For Long Complex SFA-Pop Lesions Including ISR And CTOs: Technical Tips And Contraindications: From The Global Registry: What Is The Best Endo Treatment For These Lesions |
|
Presenter(s):Gunnar Tepe, MD / Marianne Brodmann, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 10:48 AM - 10:53 AM | Update On The Randomized Head To Head Comparison Of In.Pact (Medtronic) And Ranger (Boston Scientific) DCBs For Complex SFA Lesions: 3- And 4-Year Results Of The COMPARE RCT: Similar Results With Different Paclitaxel Dosages |
|
Presenter(s):Dierk Scheinert, MD / Sabine Steiner, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 10:54 AM - 10:59 AM | Below The Ankle Endo Interventions In 2023: Techniques, Devices And Should Balloons Be Drug Coated Or Not |
|
Presenter(s):Marianne Brodmann, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:00 AM - 11:05 AM | New Information On The Safety And Effectiveness Of The Cook Zilver PTX DES Based On An Updated Meta-Analysis And Global Data: When Is It The Best DES; When Is It The Best Treatment: Is Distal Microembolization A Concern |
|
Presenter(s):Peter A. Schneider, MD / William A. Gray, MD / Sahil A. Parikh, MD / Michael D. Dake, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:06 AM - 11:11 AM | Updated 5-Year Results Of The IMPERIAL RCT Head To Head Comparison Of The Eluvia DES (Boston Scientific) With The Zilver PTX DES (Cook): Both Are Safe And Effective: What Are The Differences |
|
Presenter(s):Stefan Mueller-Huelsbeck, MD / William A. Gray, MD / Thomas Zeller, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:12 AM - 11:18 AM | Panel Discussion |
| NEW INFORMATION ON BTK DCBs AND DESs | |
| 11:18 AM - 11:23 AM | Advances In BTK Drug Delivery Technology And DCBs: What Have We Learned From The In.Pact Deep BTK DCB Trial And New Challenges With Treating CLTI Patients |
|
Presenter(s):Thomas Zeller, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:24 AM - 11:29 AM Power Point Presentation with Synched Audio |
5-Year Results From The AcoArt II BTK DCB RCT Show Safety With No Increased Mortality And Improved Patency Versus POBA To Treat BTK Lesions |
|
Presenter(s):Wei Guo, MD / Francesco Liistro, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:30 AM - 11:35 AM | Orbital Atherectomy Vessel Preparation To Maximize DCB Efficacy In Calcified BTK Lesions: OPTIMIZE BTK RCT 2-Year Results |
|
Presenter(s):Thomas Zeller, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:36 AM - 11:41 AM | The Sirolimus DCB BTK Era Begins: The SELUTION DCB (From MedAlliance And Cordis): Why The FDA Considered It A Breakthrough Device: Results From Singapore And Europe Are Promising And Justified The Ongoing SELUTION4BTK IDE Trial: Preliminary Results |
|
Presenter(s):Patrick J... Geraghty, MD / George L. Adams, MD / Michael K.W. Lichtenberg, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:42 AM - 11:47 AM | Why Some BTK DCB Trials Have Not Shown Uniformly Better Results: Technical And Balloon Factors Matter |
|
Presenter(s):Francesco Liistro, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:48 AM - 11:53 AM | Three-Year Results For The BioMimics 3D Swirling Flow Stent Show Why It Is The Most Cost-Effective Stent Of Choice For CLTI Patients |
|
Presenter(s):Michael K.W. Lichtenberg, MD / Bret Wiechmann, MD / Amy Yip, PhD / Peter Gaines, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:54 AM - 12:00 PM | Panel Discussion |
| View Slides in PDF | |
| 12:00 PM - 1:35 PM | Celebratory Lunch Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 26 | |
| SESSION 27 SCHEDULE | |
|
Wednesday
SESSION 27:
PROGRESS IN EXOTIC AND EXTREME NEW TREATMENTS FOR VERY DISTAL LOWER EXTREMITY DISEASE CAUSING ADVANCED CLTI: OPTIONS TO SAVE THE “NO OPTION FOR TREATMENT” LIMB AND THE “DESERT FOOT”
|
|
| x | |
| 1:35 PM - 1:40 PM | DEBATE: IVUS Is Useful In The Majority Of Lower Extremity Interventional Treatments |
|
Presenter(s):Eric A. Secemsky, MD, MSc Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 1:41 PM - 1:46 PM | DEBATE: Not So: Peri-Procedural Duplex Scanning May Be Better And Cheaper Than IVUS For Improved Imaging In Most Lower Extremity Intervention |
|
Presenter(s):Enrico Ascher, MD / Natalie A. Marks, MD, RPVI, RVT, FSVM Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 1:47 PM - 1:52 PM | No Option CLTI: Why Is It A Misnomer: Hybrid And Other Actual Options For Treatment And Limb Salvage |
|
Presenter(s):Hisham Rashid, FRCS, FRCS(Gen) Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| VALUE OF PROSTHETIC (PTFE) TIBIAL BYPASSES | |
| 1:53 PM - 1:58 PM | What Are The Best Options For Limb Salvage When A Single Autologous Vein Is Inadequate: Does The BEST-CLI RCT Help |
|
Presenter(s):Joseph L. Mills, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 1:59 PM - 2:04 PM | PTFE Bypasses To Infrapopliteal Target Arteries Can Save Limbs In Patients Facing Imminent Amputation With No Other Therapeutic Option: They Can Have Worthwhile Long-Term Patency And Limb Salvage Rates: A Multicenter Experience |
|
Presenter(s):Hasan H. Dosluoglu, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 2:05 PM - 2:10 PM | For Patients Facing Amputation With No Endo Options Or Useable Vein, PTFE Tibial Bypasses Are A Worthwhile Option That Yields Acceptable Mid-Term Patency And Long-Term Limb Salvage Rates |
|
Presenter(s):R. Clement Darling III, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 2:11 PM - 2:16 PM | Current Outcomes With PTFE Bypasses To Infrapopliteal (Tibial) Targets: Why Is There Variability Between Surgeons And Institutions: How Does The BEST-CLI Trial Help |
|
Presenter(s):Matthew T. Menard, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| UPDATE ON FOOT VEIN ARTERIALIZATION FOR CLTI | |
| 2:17 PM - 2:22 PM | Long-Term View Of The Role And Value Of Vein Arterialization: Best Way To Do It And Late Results: From The First To Make It Work |
|
Presenter(s):Pramook Mutirangura, FRCS (Edinburgh) Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 2:23 PM - 2:28 PM | Endovascular And Surgical Venous Arterialization For REAL No Option Patients Facing Amputation From CLTI: Does Neo-Angiogenesis Occur |
|
Presenter(s):Roberto Ferraresi, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 2:29 PM - 2:34 PM | Pivotal US Trial (PROMISE II), US Feasibility Study (PROMISE I) And European 2-Year Registry Results With Deep Vein Arterialization Using The LimFlow Device For CLTI With Gangrene Shows Reasonable Limb Salvage And Wound Healing |
|
Presenter(s):Daniel G. Clair, MD / Andrej Schmidt, MD / Daniela Branzan, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 2:35 PM - 2:40 PM | What’s New In Gene And Stem Cell Therapy For No Option CLTI In 2023 |
|
Presenter(s):Richard J. Powell, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 2:41 PM - 2:46 PM | Importance Of Open Surgical Procedures In A Limb Preservation Practice: What Are They And When Should They Be Used: It Is No longer About In Situ Vein Bypasses |
|
Presenter(s):Richard F. Neville, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 2:47 PM - 2:53 PM | Panel Discussion |
| END OF SESSION 27 | |
| SESSION 28 SCHEDULE | |
|
Wednesday
SESSION 28:
NEW DEVELOPMENTS IN STENTS; PROSTHETIC GRAFTS; ENDOVASCULAR BYPASSES; STENT GRAFTS AND TREATMENT OF IN STENT RESTENOSIS (ISR)
Location: Grand Ballroom East, 3rd Floor
Moderators:Timothy M. Sullivan, MD / Mark A. Adelman, MD / Anahita Dua, MD, MS, MBA |
|
| x | |
| 2:53 PM - 2:58 PM | Value Of Heparin Bonded PTFE Grafts For Femoral To Below-The-Knee Bypasses: A Systematic Review And Meta-Analysis: Are There Advantages To Propaten Grafts: Value To Crural Targets |
|
Presenter(s):Yann Gouëffic, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 2:59 PM - 3:04 PM | Improved Method For Restoring Patency To Occluded PTFE Bypasses Using A Fluoroscopically Guided Adherent Clot Remover (From Edwards): It’s Less Invasive And More Effective |
|
Presenter(s):Neal S. Cayne, MD / Frank J. Veith, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| PERCUTANEOUS BYPASSES | |
| 3:05 PM - 3:10 PM | Percutaneous (PQ) Transvenous Fempop PTFE Bypasses With The Torus 2 Device (Now From Endologix): How It Works And Updated Status Of The DETOUR And TORUS Trials In The US With 2-Year Results |
|
Presenter(s):Sean P. Lyden, MD / Daniel G. Clair, MD / Peter A. Schneider, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 3:11 PM - 3:16 PM | Updated Late European Results Of The Detour PQ Fempop Arterial Bypass Routed Through The Femoral Vein From The DETOUR 1 Trial: Which Open Bypasses Will Be Made Obsolete |
|
Presenter(s):Dainis K. Krievins, MD / Peter A. Schneider, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 3:17 PM - 3:22 PM | A Novel Technique For Percutaneous Extravascular Fempop Bypass - Routing A PTFE Graft Through The Soft Tissue Of The Thigh: It Is A Transcatheter Technique That Is Clampless, Sutureless, And Without External Exposure: How Is It Done; Advantages And Results |
|
Presenter(s):Pierre G. Sarradon, Docteur / Jean Pierre Becquemin, MD, FRCS Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 3:23 PM - 3:28 PM | Panel Discussion |
| NEW INFORMATION ON STENT-GRAFTS | |
| 3:28 PM - 3:33 PM | Can Viabahn Stent-Grafts Be Used Safely And Effectively In The SFA For CLTI: From Pooled Multicenter Data: What Are The Limitations Of These Devices |
|
Presenter(s):Michel M.P. Reijnen, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 3:34 PM - 3:39 PM | Performance Of A New Generation Balloon Expandable Stent-Graft (VBX From Gore) For Peripheral Aneurysmal And Occlusive Disease As Well As Bridging Stent For F/B/EVAR |
|
Presenter(s):Rocco Giudice, MD / Ciro Ferrer, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| TREATMENT OF IN STENT RESTENOSIS (ISR) | |
| 3:40 PM - 3:45 PM | Update On The Excimer Laser For Treating ISR: It Has A Role In Crossing And Debulking Difficult Lesions: Technical Tips |
|
Presenter(s):Craig M. Walker, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 3:46 PM - 3:51 PM | How Best To Treat Long Difficult Complex SFA Lesions Including Those From ISR |
|
Presenter(s):Sonia Ronchey, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 3:52 PM - 4:03 PM | Panel Discussion And Break (Visit Exhibits And Pavilions – 2nd and 3rd Floors) |
| END OF SESSION 28 | |
| SESSION 29 SCHEDULE | |
|
Wednesday
SESSION 29:
LOWER EXTREMITY TRIALS; GUIDELINES; FOOT PERFUSION EVALUATION METHODS AND VALUE OF ANGIOSOMES
Location: Grand Ballroom East, 3rd Floor
Moderators:Brian G. DeRubertis, MD / Mark K. Eskandari, MD / Frank J. Veith, MD |
|
| x | |
| 4:03 PM - 4:08 PM | The Japanese SPINACH Registry Confirms That Open Bypasses Are Superior To Endovascular Treatments In CLTI Patients When Ischemia And Infection Are Advanced |
|
Presenter(s):Nobuyoshi Azuma, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 4:09 PM - 4:14 PM | The Global Vascular Guidelines And WIfI Staging For CLTI Are Better Than Obsolete TASC Guidelines Because Treatment Recommendations, Revascularization Strategies And Needs For The Future Are Not Solely Based On Lesion Anatomy But Are Nuanced By Other Factors: What Are They |
|
Presenter(s):Michael S. Conte, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 4:15 PM - 4:20 PM | Ancillary Outcomes Of The BEST-CLI RCT Comparing Endovascular And Open Treatment For CLTI When Both Treatments Are Feasible; What Are The Deficiencies In BEST-CLI And Why Might Interventionalists Claim It Is Misleading |
|
Presenter(s):Alik Farber, MD, MBA / Matthew T. Menard, MD / Kenneth Rosenfield, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 4:21 PM - 4:26 PM | Why Many Interventionalists Believe The Conclusions Of Best-CLI (Which Involved Mostly Fempop Treatments) Are Misleading |
|
Presenter(s):Sahil A. Parikh, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 4:27 PM - 4:32 PM | Key Findings From The Just Completed BASIL 2 RCT Comparing Open And Endovascular Treatments For Severe Leg Ischemia From Mostly BTK Disease: How Do They Mesh With BEST-CLI Results |
|
Presenter(s):Andrew W. Bradbury, MD, FRCSEd Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 4:33 PM - 4:38 PM | Panel Discussion |
| METHODS FOR EVALUATING FOOT PERFUSION | |
| 4:39 PM - 4:44 PM | How And Why To Measure Foot Perfusion During And After Endo Treatments: Hyperspectral Imaging, O2 Sensors, Etc: When Is The Angiosome Concept Helpful; When Not |
|
Presenter(s):Marianne Brodmann, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 4:45 PM - 4:50 PM | New Methods For Evaluating The Significance Of Lower Extremity Arterial Lesions And Foot Perfusion Using Fractional Flow Reserve (FFR) And MRI; How They Work And Their Value In Assessing Therapeutic Success |
|
Presenter(s):Bijan Modarai, PhD, FRCS Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 4:51 PM - 4:56 PM | What Are The Best Methods For Measuring Foot Perfusion: They Are Invaluable In CLTI For Assessing Treatment Success And Predicting Healing |
|
Presenter(s):Werner Lang, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 4:57 PM - 5:02 PM | Panel Discussion |
| END OF SESSION 29 | |
| SESSION 30 SCHEDULE | |
|
Wednesday
SESSION 30:
NEW DEVELOPMENTS IN THE TREATMENT OF INTERMITTENT CLAUDICATION (IC) AND ACUTE LIMB ISCHEMIA (ALI)
|
|
| x | |
| INTERMITTENT CLAUDICATION (IC) | |
| 5:02 PM - 5:07 PM Power Point Presentation with Synched Audio |
An RCT After 2 Years Showed That Stent Treatment For Intermittent Claudication (IC) Improves Quality Of Life More Than Medical Treatment And Exercise: Do The Long-Term Results Refute Or Negate The 2-Year Results |
|
Presenter(s):Hans Lindgren, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 5:08 PM - 5:13 PM | At 2 Years After Endovascular Interventions For IC, Only 32% Of Patients Were Free From Recurrent IC: From A VQI Multicenter Study: What Are The Implications |
|
Presenter(s):Peter F. Lawrence, MD / Karen Woo, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 5:14 PM - 5:19 PM | When Are Invasive Vascular Treatments Justified For IC And When Are They Not: What Is The Evidence |
|
Presenter(s):Caitlin W. Hicks, MD, MS / James H. Black, III, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 5:20 PM - 5:25 PM | With Critical ALI, Catheter Based Aspiration Techniques Should Be Considered First-Line Therapy: When Should Other Treatments Be Used |
|
Presenter(s):Mathew D. Wooster, MD, MBA Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 5:26 PM - 5:31 PM | Panel Discussion |
| ACUTE LIMB ISCHEMIA (ALI) (See Also Session 63) | |
| 5:31 PM - 5:36 PM | Key Points In The Diagnosis And Treatment Of ALI In The Lower Limbs: When To Use Endovascular Treatments And When To Use Open Treatments With Thrombectomy Or A Bypass Because Such ALI Is Always Associated With Chronic Occlusive Disease |
|
Presenter(s):Martin Björck, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 5:37 PM - 5:42 PM | The PROMOTE-ALI Study Shows That Open Surgery Is Still Number One In The Treatment Of ALI |
|
Presenter(s):Katariina M. Noronen, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 5:43 PM - 5:48 PM | Endovascular Mechanical Thrombectomy Is Obviating The Need For Thrombolytics In ALI: Which Device Is Best – When And Why |
|
Presenter(s):Patrick E. Muck, MD, FACS Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 5:49 PM - 5:54 PM | Percutaneous Vacuum Thrombectomy For ALI: Devices And Techniques: In 2023 When Is There A Role For Thrombolytics, Angioplasty, Open Balloon Catheter Thrombectomy Or A Bypass |
|
Presenter(s):Scott L. Stevens, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 5:55 PM - 6:00 PM | What Is New With Penumbra Indigo Clot Aspiration Systems: What Makes Them Different: Indications And Contraindications |
|
Presenter(s):James F. Benenati, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 6:01 PM - 6:06 PM | Update On How To Treat ALI Under Duplex Ultrasound Guidance: Advantages And Limitations |
|
Presenter(s):Natalie A. Marks, MD, RPVI, RVT, FSVM / Enrico Ascher, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 6:07 PM - 6:12 PM | The STRIDE Multicenter Trial Showed That Mechanical Suction Thrombectomy With The Indigo Aspiration System (Penumbra) For Lower Limb ALI Had A Low Complication Rate And Excellent Limb Salvage: When Was Angioplasty, Stenting Or A Bypass Necessary |
|
Presenter(s):Thomas S. Maldonado, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 6:13 PM - 6:20 PM | Panel Discussion End of Program D |
| END OF SESSION 30 | |
| SESSION 31 SCHEDULE | |
|
Wednesday
SESSION 31:
ADVANCES IN MEDICAL TREATMENTS, NEW ANTI-ATHEROGENIC DRUGS, VALUE OF RIVAROXABAN AND PREVENTING MIs IN VASCULAR SURGERY PATIENTS
|
|
| x | |
| 6:40 AM - 6:45 AM | When, Why And How To Lower High Triglyceride Levels: Value Of Vascepa To Decrease Cardiac Risk In Vascular Patients: Based On The REDUCE-IT RCT |
|
Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 6:46 AM - 6:51 AM | New Strategies On How To Avoid And Treat Periprocedural Myocardial Infarctions (MIs) In Open Endo Vascular Surgery Patients |
|
Presenter(s):Peter Henke, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 6:52 AM - 6:57 AM | DEBATE: LDL Cholesterol (LDL-C) Lowering And Statins For Prophylaxis Of Vascular Events Are Dangerous And Not Helpful: What Does The Latest Evidence Show |
|
Presenter(s):Sherif A.H. Sultan, MD, FRCS, EBQS-VASC, PhD, FACS Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 6:58 AM - 7:03 AM | DEBATE: Not So: Update On LDL-C Lowering With Statins And Other Drugs Stabilizes And Shrinks Plaques And Decreases Morbid Vascular Events: Stopping Statins Increases Patients’ Risk Of MI And Death |
|
Presenter(s):Ron Waksman, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:04 AM - 7:09 AM | Update On LDL-C Lowering During A Lifetime: How Low To Strive For With Intensive Drug Therapy: How Young To Start If High; How Old To Continue Statins: Why And How Often Should LDL-C Levels Be Measured |
|
Presenter(s):J. David Spence, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:10 AM - 7:15 AM | LDL-C Lowering Should Be Maximized With High Dose Statins And Ezetimibe (Zetia) To Minimize Risks From Atherosclerotic Lesions: The LDL-C Level Cannot Be Too Low And Side Effects Are Minor: LDL-C Levels Must Be Monitored And Treated To A Target Level |
|
Presenter(s):Anne L. Abbott, MD, PhD, FRACP Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:16 AM - 7:21 AM | New Findings From The VOYAGER PAD And COMPASS Trials With Low Dose Rivaroxaban (Xarelto From Janssen And J&J) And Aspirin: How Do These Drugs Lower Major Adverse Limb And Cardiac Event Rates After Lower Extremity Revascularization (Endo And Open) For PAD |
|
Presenter(s):Marianne Brodmann, MD / Sebastian E. Debus, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:22 AM - 7:27 AM | How Does The Morbidity And Pathology Of Adverse Events With Arteriosclerosis Depend On Thrombosis: This Explains The Benefits Of Rivaroxaban And Aspirin Seen In The VOYAGER And COMPASS Trials |
|
Presenter(s):Anthony J. Comerota, MD, FACS, FACC Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:28 AM - 7:33 AM | New Adjunctive Drugs (Plus Statins) To Lower LDL-Cholesterol (LDL-C) In Vascular Patients: Inclisiran, Bempedoic Acid And Ezetimibe: How Do They Work And When And How To Use Them: Level Of LDL-C To Strive For: The CLEAR RCT Show That Bempedoic Acid Really Works |
|
Presenter(s):Richard Bulbulia, MA, MD, FRCS Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:34 AM - 7:42 AM | Panel Discussion |
| END OF SESSION 31 | |
| SESSION 32 SCHEDULE | |
|
Wednesday
SESSION 32:
CATHETER BASED TREATMENTS OF RESISTANT HYPERTENSION; MANAGEMENT OF CARDIAC PROBLEMS, SMOKING AND TRANSFUSION IN VASCULAR SURGERY PATIENTS; MORTALITY RISK IN STROKE PATIENTS; PREVENTING VASCULAR AND CARDIAC COMPLICATIONS
|
|
| x | |
| UPDATE ON RENAL DENERVATION FOR HYPERTENSION | |
| 7:42 AM - 7:47 AM | Update On The Status Of Renal Denervation For Hypertension: It Is Here To Stay: Where Is It Going: Status Of The Radiofrequency Denervation SPYRAL HTN-OFF MED RCT (vs Sham) And Other Catheter-Based Ablative And Ultrasound Methods (The RADIANCE II RCT Findings) |
|
Presenter(s):Eric A. Secemsky, MD, MSc Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:48 AM - 7:53 AM | Multiorgan Denervation For Treatment Of Hypertension, Diabetes And Metabolic Syndrome: How To Do It |
|
Presenter(s):Kolja Sievert, MD / Horst Sievert, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:54 AM - 7:59 AM | A Precision Medicine Approach To Managing Pediatric Renovascular Hypertension: How Can Medical And Open Surgical Treatment Control It |
|
Presenter(s):Dawn M. Coleman, MD, FACS Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| OTHER TOPICS RELATED TO VASCULAR DISEASE AND ITS TREATMENT | |
| 8:00 AM - 8:05 AM | How Does The Female Sex Impact The Occurrence Of Lower Extremity Atherosclerosis, Its Treatment And Results Of Treatment |
|
Presenter(s):Katherine A. Gallagher, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 8:06 AM - 8:11 AM | How And Why Do Thoracic Endografts For TEVAR Negatively Affect The Blood Pressure And The Heart: Can A Compliant Endograft Prevent The Problem |
|
Presenter(s):Frans L. Moll, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 8:12 AM - 8:17 AM | When Should Smoking Be Stopped Before AAA Repair; Before Lower Extremity Bypass: At Least 4 Weeks: Why Does The Duration Of Cessation Matters |
|
Presenter(s):Jeffrey J. Siracuse, MD, MBA, FACS Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 8:18 AM - 8:23 AM | Update On Limiting Transfusion And Permitting Anemia After Major Vascular Operations Increases Mortality And Serious Adverse Events Especially In Patients With Cardiac Co-Morbidities |
|
Presenter(s):Panos Kougias, MD, MSc Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 8:24 AM - 8:29 AM | How To Quantitate Late Mortality Risk In Asymptomatic Carotid Stenosis (ACS) Patients: Why It’s Important In Deciding To Treat ACS Patients Non-Invasively |
|
Presenter(s):Stavros K. Kakkos, MD, PhD / Andrew N. Nicolaides, MS, FRCS Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 8:30 AM - 8:35 AM Power Point Presentation with Synched Audio |
Secondary Prevention Of Vascular Disease And Its Complication With PCSK9 Inhibitors; When They Should Be Used And When Not: How Well Does The New Oral PCSK9 (Inhibitor MK-01616 Work) |
|
Presenter(s):Roxana Mehran, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 8:36 AM - 8:41 AM | How Important Is Inflammation As Determined By C-Reactive Protein (CRP) Levels In Predicting Adverse Cardiac Events: What Drugs Can Lower This Risk |
|
Presenter(s):Ron Waksman, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 8:42 AM - 8:50 AM | Panel Discussion |
| 8:50 AM - 9:06 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 32 | |
| SESSION 33 SCHEDULE | |
|
Wednesday
SESSION 33:
PROGRESS IN MANAGING ENDOLEAKS: UNDERSTANDING THEIR CONSEQUENCES AND PREDICTING, PREVENTING AND TREATING THEM
|
|
| x | |
| TO TREAT OR NOT TO TREAT TYPE 2 ENDOLEAKS | |
| 9:06 AM - 9:11 AM | Active AAA Sac Management With Polymers: This Is The Missing Link To Improve Outcomes After EVAR: Technique And Results From The SHAPE AAA-Trial |
|
Presenter(s):Michel M.P. Reijnen, MD, PhD / Andrew Holden, MBChB Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 9:12 AM - 9:17 AM | Fibrin Glue Sac Filling Technique During EVAR To Prevent All Endoleaks: It Should Be Routine And Is A Game Changer Based On A Multicenter Trial: How To Do It |
|
Presenter(s):Qingsheng Lu, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| TREATING TYPE 1 ENDOLEAKS | |
| 9:18 AM - 9:23 AM | Post EVAR Type 1A Endoleaks Are Predictable And Preventable: Strategies To Prevent Them Or Treat Them |
|
Presenter(s):Michael J. Singh, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 9:24 AM - 9:29 AM | Embolization Of Type 1 Endoleaks Post EVAR: Longer Term Outcomes; Who To Select For The Procedure And Tips And Tricks For Doing It |
|
Presenter(s):Robert A. Morgan, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 9:30 AM - 9:35 AM | When And How To Use Embolization Coils To Treat Type 1A Endoleaks Successfully: When Won’t Coils Work: How To Diagnose Type 1A Endoleaks Accurately |
|
Presenter(s):Sigrid Nikol, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 9:36 AM - 9:41 AM | How To Minimize Gutter Type 1A Endoleaks With Chimney EVAR (Ch/EVAR): How Does A Standard Protocol Help; How To Treat Them When They Occur |
|
Presenter(s):David J. Minion, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 9:42 AM - 9:48 AM | Panel Discussion |
| 9:49 AM - 9:54 AM | A RCT Shows The Advantages Of Inferior Mesenteric Artery (IMA) And Lumbar Embolization: The Next Generation Of EVAR Endografts Must Prevent Endoleaks: How Can It Be Done |
|
Presenter(s):Dominique Fabre, MD, PhD / Stephan Haulon, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 9:55 AM - 10:00 AM | Preventing Threatening Type 2 Endoleaks By IMA Embolization When AAA Sac And IMA Are Large: Indications And Technical Tips And Evidence |
|
Presenter(s):Toru Kuratani, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 10:01 AM - 10:06 AM | With A Large IMA (> 3mm), When Should It Be Embolized; Or When Should It Be Revascularized: How And Why |
|
Presenter(s):Piotr M. Kasprzak, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 10:07 AM - 10:12 AM | Reduction Of Type 2 Endoleaks By Pre-Emptive Coiling Of Aortic Side Branches >3 mm: How Do We Know Based On A Mid-Term Analysis |
|
Presenter(s):Götz M. Richter, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 10:13 AM - 10:19 AM | Panel Discussion |
| TREATMENT OF TYPE 2 ENDOLEAKS AND ENDOTENSION AFTER EVAR | |
| 10:20 AM - 10:25 AM | Transcaval Approach To Treat Type 2 Endoleaks After EVAR: Indications: Technique; Precautions And Results |
|
Presenter(s):Ross Milner, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 10:26 AM - 10:31 AM | Glue Embolization Is Effective Treatment For Most Threatening Type 2 Endoleaks: When And How Best To Do It: Limitations |
|
Presenter(s):Neal S. Cayne, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 10:32 AM - 10:37 AM | New Concepts In Post EVAR Endoleaks And Endotension: The Role Of Fabric Fatigue, Concealed Or Positional Endoleaks And AAA Sac Hygromas: How Can These Be Detected And Best Treated |
|
Presenter(s):Sherif A.H. Sultan, MD, FRCS, EBQS-VASC, PhD, FACS Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 10:38 AM - 10:43 AM | How To Use 3D Fusion Software (GE) To Get Into The Nidus And Treat Type 2 Endoleaks: Best Embolic Agent And Alternate Approaches (Transgraft Or Transcaval) For Access: How To Seal The Graft Puncture Site |
|
Presenter(s):Mark W. Mewissen, MD, RVT Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 10:44 AM - 10:49 AM | Laser Assisted Transgraft Onyx Embolization Of Type 2 Endoleaks: Indications, Equipment And Technique: How Is The Graft Puncture Site Revealed |
|
Presenter(s):Zvonimir Krajcer, MD, FACC Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 10:50 AM - 10:55 AM | Most Type 2 Endoleaks After EVAR Should Be Left Alone Because Treatments Have Poor Results, Have Complications And Do Not Improve Outcomes: Are There Exceptions |
|
Presenter(s):Hence J.M. Verhagen, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 10:56 AM - 11:01 AM | With Type 2 Endoleaks And Sac Expansion, Open Sacotomy And Branch Ligation Is Often The Best Treatment: What Precautions Are Needed In Case There Is An Occult Type 1 Leak |
|
Presenter(s):Zachary M. Arthurs, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 11:02 AM - 11:11 AM | Panel Discussion |
| END OF SESSION 33 | |
| SESSION 34 SCHEDULE | |
|
Wednesday
SESSION 34:
TCT AND PLINIO ROSSI RECORDED LIVE COMPLEX AND CHALLENGING ENDOVASCULAR CASES
|
|
| x | |
| Moderator(s): D. Christopher Metzger, MD / Sahil A. Parikh, MD | |
| 11:12 AM - 11:36 AM | Complex Subclavian Pseudoaneurysm After Impella Explant |
| PLINIO ROSSI’S RECORDED LIVE COMPLEX AND CHALLENGING ENDO CASES | |
| Moderator(s): Fabrizio Fanelli, MD, EBIR / Andrew Holden, MBChB / Carlo Setacci, MD | |
| 11:36 AM - 11:43 PM | Renal Bridging Stent Rescue After EVAR |
|
Presenter(s):Nicola Mangialardi, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 11:43 AM - 11:48 AM | Discussion |
| 11:48 AM - 11:55 AM | BTK Angioplasty In A CLTI Patient: Never Give Up |
|
Presenter(s):Roberto Ferraresi, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 11:55 AM - 12:00 PM | Discussion |
| 12:00 PM - 1:35 PM | Celebratory Lunch Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 34 | |
| SESSION 35 SCHEDULE | |
|
Wednesday
SESSION 35:
RECORDED LIVE CHALLENGING CASES AND INNOVATIVE TECHNIQUES FROM THE LINC GROUP
Location: Grand Ballroom West, 3rd Floor
Moderators:Dierk Scheinert, MD / Andrej Schmidt, MD / Daniela Branzan, MD |
|
| x | |
| 1:35 PM - 1:46 PM | Presentation: Calcium In BTK: What Are The Options |
|
Presenter(s):Andrej Schmidt, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 1:46 PM - 1:57 PM | Recorded Case: Long Segment BTK Revascularization With Orbital Atherectomy And DCB |
| 1:57 PM - 2:07 PM | Recorded Case: Reconstruction Of The Tibioperoneal Trifurcation With DES |
| END OF SESSION 35 | |
| SESSION 36 SCHEDULE | |
|
Wednesday
SESSION 36:
ISSUES IMPORTANT IN VASCULAR SURGERY: PRACTICE PATTERNS, HISTORY, EFFICIENCY, MALPRACTICE, SCIENCE, TRAINING AND HUMAN BEHAVIOR
|
|
| x | |
| 2:08 PM - 2:13 PM | Care Fragmentation In Vascular Treatment: What Is It; What Are Its Causes And What Is Its Impact On Outcomes After Vascular Procedures |
|
Presenter(s):Olamide Alabi, MD / William D. Jordan Jr., MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 2:14 PM - 2:19 PM | History Of Women In Surgery And Vascular Surgery: What Does The Future Hold Within The Next 10 Years |
|
Presenter(s):Cynthia K. Shortell, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 2:20 PM - 2:25 PM | How To Improve Operating Room Efficiency For Vascular Surgical Operations: Why Is Inefficiency In This Setting So Widespread And Hard To Fix |
|
Presenter(s):Panos Kougias, MD, MSc Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 2:26 PM - 2:31 PM | Why Non-Compete Clauses In Contracts Should be Eliminated By Law: The SVS Position In Favor Of Such Law Contrasts With The AHA Position Against |
|
Presenter(s):Margaret Tracci, MD, JD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 2:32 PM - 2:37 PM | Why Systematic Reviews, Meta-Analyses And RCTs Can Be Misleading: What To Do About It: Does Current Wisdom Help |
|
Presenter(s):Janet T. Powell, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 2:38 PM - 2:43 PM | Why Endovascular Treatments Are Overutilized: Who Is Responsible: How Can The Problem Be Remedied |
|
Presenter(s):Kim J. Hodgson, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 2:44 PM - 2:49 PM | Lifeline Proprietary Carotid Screening: Who Profits: Is It A Good Thing Or A Hoax; What Can It Tell Us About The Prevalence Of Asymptomatic Carotid Stenosis |
|
Presenter(s):William A. Gray, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| ISSUES IN VASCULAR TRAINING | |
| 2:50 PM - 2:55 PM | Optimal New Training Paradigm For Vascular Surgeons: 0+5 Vascular Surgery Residency Followed By 2 Years Of Cardiac Surgery Residency Training: Why Is It Better Than 2 Extra Years Of Laboratory Research |
|
Presenter(s):Alan B. Lumsden, MD, FACS Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 2:56 PM - 3:01 PM | Integrated (0+5) Vascular Residency Plus CT Surgery Fellowship – How Many Are There; Are They Over Trained And Underutilized: How Has It Helped Me |
|
Presenter(s):Jennifer L. Perri, MD, MBA Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 3:02 PM - 3:07 PM | Is Vascular Surgery Facing A Looming Decline Because Of Inadequate Numbers Of Both 5+2 And 0+5 Training Programs: What Should And Can Be Done About It: What Are The Impediments |
|
Presenter(s):Michael B. Silva, Jr., MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 3:08 PM - 3:13 PM | How To Remedy The Deficiency Vascular Fellows And Residents Have In Their Numbers Of Open Vascular Surgical Operations: When Should They Get Additional Subspecialty Training In Another Institution |
|
Presenter(s):Malachi Sheahan, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 3:14 PM - 3:19 PM | How Human Behavior – Even With Vascular Specialists – Is Controlled By Biases And Rationalizations: How To Overcome These And Perform Better |
|
Presenter(s):Scott L. Stevens, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 3:20 PM - 3:33 PM | Panel Discussion And Break (Visit Exhibits And Pavilions – 2nd and 3rd Floors) |
| END OF SESSION 36 | |
| SESSION 37 SCHEDULE | |
|
Wednesday
SESSION 37:
MORE ISSUE-RELATED TOPICS IMPORTANT TO VASCULAR SURGEONS AND VASCULAR SPECIALISTS; ISSUES RELATED TO OUTPATIENT CENTERS OR OFFICE BASED LABS (OBLs)
|
|
| x | |
| 3:33 PM - 3:38 PM | How COVID And Changes In The Economy Have Caused Hospitals To Run Out Of Money; What Is The Resulting Impact On Vascular Care And Vascular Doctors; What Can Be Done About It |
|
Presenter(s):Samuel R. Money, MD, MBA Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 3:39 PM - 3:44 PM | DEBATE: How Heart And Vascular Centers Are Attracting Private Equity Investment Leading To Benefits For All Concerned Including Vascular Surgeons And Their Patients |
|
Presenter(s):Jean Bismuth, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 3:45 PM - 3:50 PM | DEBATE: Heart And Vascular Centers Are Artificial Entities That Disadvantage Vascular Surgeons And Don’t Improve Patient Care |
|
Presenter(s):Malachi Sheahan, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 3:51 PM - 3:56 PM | Vascular Spinoff Revenue In Tertiary Healthcare Systems: Substantially More Downstream Benefits From Vascular Surgeons: How To Make Hospital Administrators Appreciate The Value Of Vascular Surgeons And Reward Them Appropriately |
|
Presenter(s):Joseph V. Lombardi, MD, MBA Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| ISSUES RELATED TO OUTPATIENT CENTERS AND OBLs | |
| 3:57 PM - 4:02 PM | The Ever Changing Reimbursement For Lower Extremity Endovascular Therapies In Hospitals And OBLs: Why It’s Happening And Where Is It Going |
|
Presenter(s):Sean P. Roddy, MD / Robert M. Zwolak, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 4:03 PM - 4:08 PM | Strategies To Succeed In An OBL Despite Continuing Cuts In CMS Reimbursement |
|
Presenter(s):Clifford M. Sales, MD, MBA, FACS Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 4:09 PM - 4:14 PM | Panel Discussion |
| MORE ISSUES RELATED TO OUTPATIENT CENTERS AND OBLs | |
| 4:15 PM - 4:20 PM | DEBATE: OBLs Are Bad: Why I Choose Not To Work In An OBL |
|
Presenter(s):Dipankar Mukherjee, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 4:21 PM - 4:26 PM | DEBATE: Not True! How Can OBLs Provide Good Vascular Care With Excellent Results, Be Profitable And Still Allow Vascular Surgeons To Only Work From 8 AM To 5 PM |
|
Presenter(s):Mark A. Mattos, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 4:27 PM - 4:32 PM | How To Make Out-Patient Vascular Treatment Facilities (OBLs, ASCs) Safe, Effective And Profitable Without Doing Unjustified Procedures |
|
Presenter(s):Christopher J. Kwolek, MD, MBA Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 4:33 PM - 4:38 PM | Comparison of Arterial Closure Devices In An OBL Setting: Which Is Best Based On An Experience With 19,000 Cases |
|
Presenter(s):Sam S. Ahn, MD, FACS, MBA Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 4:39 PM - 4:44 PM | Tips For Performing High-Risk Lower Extremity Endovascular Procedures Including Redos Safely And Effectively In An OBL |
|
Presenter(s):Anil P. Hingorani, MD / Enrico Ascher, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 4:45 PM - 4:50 PM | OBL Audits: What Are They Looking For And How To Avoid Civil And Criminal Penalties: Do Practice Guidelines Help Or Harm |
|
Presenter(s):O. William Brown, MD, JD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 4:51 PM - 4:56 PM | Panel Discussion |
| END OF SESSION 37 | |
| SESSION 38 SCHEDULE | |
|
Wednesday
SESSION 38:
UPDATES AND ISSUES IMPORTANT TO ALL VASCULAR SURGEONS AND SPECIALISTS: FUTURE REIMBURSEMENT; VASCULAR REGISTRIES AND THE VQI, VALUE OF GUIDELINES AND RCTs: THE FDA: STATISTICS; EVIDENCE BASED MEDICINE; MISCELLANEOUS
|
|
| x | |
| 4:57 PM - 5:02 PM | What Obstacles And Blows Are Vascular Surgeons And Other Vascular Specialists Facing In 2023: Will Planned Increased Reimbursement For Office And Hospital Visits Cause More Decreases In Procedural Reimbursements |
|
Presenter(s):Sean P. Roddy, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 5:03 PM - 5:08 PM | VQI Collaboration With The International Consortium of Vascular Registries (ICVR): How Can It Better Evaluate Aortic Endograft Performance |
|
Presenter(s):Adam Beck, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 5:09 PM - 5:14 PM Power Point Presentation with Synched Audio |
The Role And Value Of Guidelines And RCTs In Vascular Practice; Why Guidelines And RCTs Can Be Misleading: What To Do About The Problem |
|
Presenter(s):Anders Wanhainen, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| REGULATORY AND FDA ISSUES | |
| 5:15 PM - 5:20 PM | How Can A Device Qualify With The FDA For BREAKTHROUGH Status And How Does It Differ From SAFER Status |
|
Presenter(s):Valerie M. Merkle, PhD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 5:21 PM - 5:26 PM | Past, Present And Future Collaboration Between Industry, Clinicians And The FDA To Address Unmet Clinical Needs: We Should Not Be Adversaries |
|
Presenter(s):Dorothy B. Abel, BSBME Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| EVIDENCE-BASED MEDICINE ISSUES | |
| 5:27 PM - 5:32 PM | Improved And Simplified Clinical Trial Statistics For Dummies: Why p Values Are Decreasing In Importance And Bayesian Statistics Are Increasing In Importance: What Is The Latter |
|
Presenter(s):Charles C. Miller, PhD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 5:33 PM - 5:38 PM | Registry Based RCTs (RBRCTs): What Are They, How Do They Work And Why Are They Better Than Other Evidence-Based Techniques |
|
Presenter(s):Jens Eldrup-Jorgensen, MD / Jack L. Cronenwett, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 5:39 PM - 5:44 PM | Panel Discussion |
| MISCELLANEOUS | |
| 5:45 PM - 5:50 PM | Managing Various Specialties And Generations Of Specialists In A Multi-Specialty Vascular Institute Or Center: How To Satisfy Everyone And Optimize Patient Outcomes |
|
Presenter(s):Gary M. Ansel, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 5:51 PM - 5:56 PM | Despite What The New York Times And Others Say, Close Relationships Of Vascular Surgeons With Industry Are Mostly Ethical And Beneficial To Patients And Society: Pitfalls To Avoid |
|
Presenter(s):Bruce A. Perler, MD, MBA Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 5:57 PM - 6:02 PM | Innovation In Vascular Surgery: Ideas, Funding, Partners And Intellectual Property: How To Turn Fantasy Into Reality |
|
Presenter(s):Jeffrey H. Lawson, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 6:03 PM - 6:08 PM | Current Quality Analysis For Vascular Surgeons And Vascular Specialists Does Not Reflect Quality Of Care: Why And What Can Be Done About It |
|
Presenter(s):Richard F. Neville, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 6:09 PM - 6:14 PM | Editorial Update On The JVS And All Its Progeny: Its Status And How It Will Be Improved |
|
Presenter(s):Ronald L. Dalman, MD / Thomas L. Forbes, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 6:15 PM - 6:20 PM | Effects Of The Affordable Care Act (ACA) On Vascular Surgical Outcomes: Does The Medicaid Expansion Of The ACA Improve Outcomes Or Not |
|
Presenter(s):Mohammad H. Eslami, MD, MPH Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 6:21 PM - 6:30 PM | Panel Discussion End of Program E |
| END OF SESSION 38 | |
| SESSION 39 SCHEDULE | |
|
Wednesday
SESSION 39:
MORE TOPICS RELATED TO THE THORACIC AORTA, AORTIC DISSECTIONS, INTRAMURAL HEMATOMAS (IMHs), INFLAMMATORY ANEURYSMS AND THEIR TREATMENT
Location: Trianon Ballroom, 3rd Floor
Moderators:Ramon Berguer, MD, PhD / Paulo E. Ocke Reis, MD, PhD |
|
| x | |
| 6:50 AM - 6:55 AM | What Is Best Medical Treatment For TBAD Patients: How Best To Control Blood Pressure And To Get Patients To Comply: They Don’t |
|
Presenter(s):Colin D. Bicknell, MD, FRCS Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 6:56 AM - 7:01 AM | Requirement For Adjunctive Branch Stents After TEVAR For Complicated TBADs Is An Indicator Of Poor Prognosis: What Can Be Done To Offset It |
|
Presenter(s):Mark K. Eskandari, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 7:02 AM - 7:07 AM | Current Optimal Management Of Intramural Hematomas (IMHs): Which Ones Should Be Treated With TEVAR And What Is The Best Extent Of Aortic Coverage |
|
Presenter(s):Frank J. Criado, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 7:08 AM - 7:13 AM | Outer/ Inner/Upward Branches Or Fenestrations: Strategies For Complex Aortic Repair For Patients With Chronic TBADs: What Are The Unmet Needs |
|
Presenter(s):Bijan Modarai, PhD, FRCS Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 7:14 AM - 7:19 AM | Current Advances In The Treatment For Inflammatory Aneurysms: How Effective Are EVAR And TEVAR |
|
Presenter(s):Furuzan Numan, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 7:20 AM - 7:25 AM | Panel Discussion |
| 7:25 AM - 7:30 AM | DEBATE: The STABILISE Technique Will Lead To Paradigm Shift In The Treatment Of TBADs And Will Replace Most False Lumen Occlusion Devices And F/B/EVAR Treatments: It Relaminates The Aorta And Eliminates The False Lumen: How To Do It And Precautions |
|
Presenter(s):Igor A. Laskowski, MD, PhD / Josh B. Goldberg, MD / Heepeel Chang, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 7:31 AM - 7:36 AM | DEBATE: Not So Fast! A Multimodular Approach To Treating Chronic TBADs With TAAAs: Who Needs A F/B/EVAR; Who Needs A Candy-Plug Or Other Occlusion Technique |
|
Presenter(s):Tilo Koelbel, MD, PhD / Fiona Rohlffs, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 7:37 AM - 7:42 AM | When Are Thoracic Endografts Valuable Treatments For Genetic Aortopathies |
|
Presenter(s):Cherrie Z. Abraham, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 7:43 AM - 7:48 AM | What Are The Knowledge Gaps In The Treatment Of TBADs: How Can And Will They Be Resolved |
|
Presenter(s):Colin D. Bicknell, MD, FRCS Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 7:49 AM - 7:54 AM | A Recently Funded Multicenter NIH Grant (IMPROVE-AD) To Evaluate Unknowns In The Treatment Of Acute And Subacute TBADs: What Will It Tell Us And Why Was It So Hard To Get It Approved: Are There Other Similar RCTs Outside The US |
|
Presenter(s):Gustavo S. Oderich, MD, FACS Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 7:55 AM - 8:00 AM | Panel Discussion |
| END OF SESSION 39 | |
| SESSION 40 SCHEDULE | |
|
Wednesday
SESSION 40:
MORE ADVANCES RELATED TO TREATING PATHOLOGY INVOLVING THE ASCENDING AORTA AND THE AORTIC ARCH; AORTIC DISSECTIONS AND THEIR TREATMENT
|
|
| x | |
| 8:00 AM - 8:05 AM | When In Addition To TEVAR And F/BEVAR Are False Lumen (FL) Occlusion Procedures Needed To Reduce FL Pressure And Promote Aortic Remodeling |
|
Presenter(s):Götz M. Richter, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 8:06 AM - 8:11 AM | With TAAD When And How Should The Distal Aorta Be Treated By TEVAR Before Repairing The Ascending Aorta |
|
Presenter(s):Ourania Preventza, MD / Joseph S. Coselli, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 8:12 AM - 8:17 AM | Fenestrated TEVAR Devices For The Treatment Of Post Dissection Aortic Arch False Lumen Aneurysms: What Devices Are Available, How Do They Work And Results |
|
Presenter(s):Nicola Mangialardi, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 8:18 AM - 8:23 AM Power Point Presentation with Synched Audio |
With Chronic TBADs Laser Assisted Resection Of The Dissection Membrane Creates A Single Lumen TEVAR Landing Zone: How Is The Technique Performed And Early Results |
|
Presenter(s):Nuno V. Dias, MD, PhD / Bjõrn Sonesson, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 8:24 AM - 8:29 AM | Continuing Experience For Precise TEVAR Placement In Or Near The Arch By Valsalva And PEEP (Munich Valsalva Maneuver): It Is Safe And Effective And Better Than Adenosine, Rapid Pacing And Caval Occlusion: How To Do It And Results |
|
Presenter(s):Nikolaos Tsilimparis, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 8:30 AM - 8:35 AM | Panel Discussion |
| 8:35 AM - 8:40 AM | Single, Double Or 3-Branched Endograft Devices For Arch Lesion Repairs: When Is Each Best And Why: How To Do It From A Totally Femoral Approach |
|
Presenter(s):Gustavo S. Oderich, MD, FACS Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 8:41 AM - 8:46 AM | An Off-The-Shelf Combined Valve+Fenestrated Endograft For Treating Acute TAADs – An Endo Bentall: Device Description, Indications And Clinical Status |
|
Presenter(s):Stephan Haulon, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 8:47 AM - 8:52 AM | Percutaneous Endovascular Arch Repair Is Feasible With The Use Of Adjuncts: The “Innominate Approach” Avoids The Need To Get Open Exposure Of The Carotid Arteries For Access: How Is It Done |
|
Presenter(s):Timothy A. Resch, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 8:53 AM - 8:58 AM | Physician Modified Double Fenestrated Stent-Grafts (PMEGs) For Total Aortic Arch Repair: Technique, Precautions And Results In 150 Cases |
|
Presenter(s):Ludovic Canaud, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 8:59 AM - 9:04 AM | Zone 0 Aortic Arch Branched Endograft Repair Is Feasible With A Mechanical Aortic Valve: Tips And Tricks For Performing It Without Impairing Valve Function |
|
Presenter(s):Nikolaos Tsilimparis, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 9:05 AM - 9:11 AM | Panel Discussion |
| 9:11 AM - 9:24 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 40 | |
| SESSION 41 SCHEDULE | |
|
Wednesday
SESSION 41:
OPEN AND ENDO TREATMENT OF COMPLEX AAAs (JUXTA, PARA- AND SUPRA-RENAL) AND TAAAs; NEW DEVICES FOR THEIR TREATMENT
Location: Trianon Ballroom, 3rd Floor
Moderators:Christopher J. Kwolek, MD, MBA / Gilbert R. Upchurch, MD |
|
| x | |
| COMPLEX AAAs AND TAAAs | |
| 9:24 AM - 9:29 AM | Aortic Neck Dilatation And AAA Sac Shrinkage After F/EVAR Is Better Than After Standard EVAR |
|
Presenter(s):Thomas S. Maldonado, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 9:30 AM - 9:35 AM | Recent Progress In Prevention Of Spinal Cord Ischemia (SCI) Especially Paraplegia After Complex AAA And TAAA Endovascular Repairs |
|
Presenter(s):Adam Beck, MD / Matthew J. Eagleton, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 9:36 AM - 9:41 AM | Complete Aortic Endovascular Repairs (Zones 0-10) Using Parallel Endografts With A Docking Station: How And Why To Make Them Work Effectively Despite Doubts About Parallel Grafts |
|
Presenter(s):Manish Mehta, MD, MPH Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 9:42 AM - 9:47 AM | Value Of Ch/EVAR For Juxtarenal AAAs: They Are As Safe And Effective As Any Other Procedure And Simpler: Based On A Meta-Analysis Of Mid-Term Outcomes |
|
Presenter(s):Joost van Herwaarden, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 9:48 AM - 9:53 AM | Key Findings From The UK-Complex Aneurysm Study (UK-COMPASS) Comparing Outcomes Of Off-Label EVAR, Open Repair And F/EVAR For Short Necked AAAs |
|
Presenter(s):S. Rao Vallabhaneni, MD, FRCS / Michael P. Jenkins, MBBS, BSc, MS, FRCS, FEBVS Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 9:54 AM - 9:59 AM | Comparison Of Endo And Open Repair Of Post Dissection TAAAs: Which Procedure Is Best And When |
|
Presenter(s):Fabio Verzini, MD, PhD, FEBVS Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 10:00 AM - 10:05 AM | What Is A Hybrid Repair Of A TAAA (Proximal Endograft + Distal Open Repair - The Upchurch Procedure): When Is It Indicated; What Are The Advantages And Results |
|
Presenter(s):Gilbert R. Upchurch, MD / Sal Scali, MD / Dean Arnaoutakis, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 10:06 AM - 10:12 AM | Panel Discussion |
| TOPICS RELATED TO INTERESTING NEW DEVICES | |
| 10:12 AM - 10:17 AM | Update On The Incraft Endograft (From Cordis) For Standard Infrarenal EVAR: Is Its Low Profile An Advantage Or Limitation |
|
Presenter(s):Giovanni B. Torsello, MD / Matteo Orrico, MD / Nicola Mangialardi, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 10:18 AM - 10:23 AM | How To Prevent Patch Aneurysms After Open TAAA Repair With Long Antegrade Grafts: How To Treat Them When They Occur |
|
Presenter(s):Manju Kalra, MBBS Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 10:24 AM - 10:29 AM | Can EVAR And F/EVAR Be Done Under Local Anesthesia: Can They Become Outpatient Procedures Or Office Based Lab Procedures: What Are The Contraindications |
|
Presenter(s):Michael C. Stoner, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 10:30 AM - 10:35 AM Power Point Presentation with Synched Audio |
WeFlow Device For Juxtarenal AAA, TAAA And Arch Repairs: A New Inner Branch And Outer Branch Approach: How Does It Work And Promising Results |
|
Presenter(s):Wei Guo, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 10:36 AM - 10:40 AM | Panel Discussion |
| END OF SESSION 41 | |
| SESSION 42 SCHEDULE | |
|
Wednesday
SESSION 42:
PROGRESS IN TREATING ILIAC LESIONS; ILIAC BRANCHED DEVICES (IBDs); UPDATE ON MULTILAYER FLOW MODULATING (MLFM) AND OTHER BARE STENTS FOR TREATING ANEURYSMS AND DISSECTIONS
|
|
| x | |
| TREATMENT OF ILIAC ANEURYSMS AND IBDs | |
| 10:40 AM - 10:45 AM | Surprisingly Occlusion Of 1 Or Both Hypogastric Arteries During EVAR Does NOT Result In Serious Adverse Events: From A Large VQI Study |
|
Presenter(s):Heepeel Chang, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 10:46 AM - 10:51 AM | Update On The Gore IBE Excluder For Treating Iliac Aneurysms And Preserving Hypogastric Artery Flow: Why It Should Be Preserved Whenever Possible: When Can It Not Be |
|
Presenter(s):Michel M.P. Reijnen, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 10:52 AM - 10:57 AM | Updated Experience With Cook IBD For The Treatment Of Common Iliac Aneurysms: Including After Previous EVAR |
|
Presenter(s):Giovanni B. Torsello, MD / Carlos H. Timaran, MD / Andres Schanzer, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 10:58 AM - 11:03 AM | Long-Term Comparison Of The Cook Zenith And Gore Excluder IBDs: Advantages And Limitations Of Both: What Is Currently The Best Bridging Stent |
|
Presenter(s):Giovanni Pratesi, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 11:04 AM - 11:09 AM | An Iliac Customized Fenestrated Device (From Terumo Aortic): When And How Can It Work In Anatomies Unsuitable For Branched Endografts: Advantages And Limitations |
|
Presenter(s):Afshin Assadian, MD / Fadi Taher, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 11:10 AM - 11:15 AM | Update On The Advantages Of The Artivion (Formerly CryoLife/Jotec) IBD Device For Treating Common And Internal Iliac Artery Aneurysms: When Bell Bottom Technique; When IBD: From The PLIANT II Study |
|
Presenter(s):Lee Bouwman, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 11:16 AM - 11:21 AM | Covered Endovascular Reconstruction Of The Iliac Bifurcation (CERIB) For Preservation Of Pelvic Flow During Treatment Of Aortoiliac Occlusive Disease: How And When To Do It |
|
Presenter(s):Joshua D. Adams, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 11:22 AM - 11:30 AM | Panel Discussion |
| UPDATE ON MULTILAYER FLOW MODULATING (MLFM) AND OTHER BARE STENTS | |
| 11:30 AM - 11:35 AM | Is There A Role For Bare Stents (Allay From Intressa, Formerly Cardiatis) In The Treatment Of Type A Aortic Dissections (TAADs) |
|
Presenter(s):Rodney A. White, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 11:36 AM - 11:41 AM | 8-Year Clinical Experience With Bare Stent And Chimney Treatment Of TAADs |
|
Presenter(s):Ivo Petrov, MD, PhD / Victor S. Costache, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 11:42 AM - 11:47 AM | 3-Year Experience With Bare Stents (Allay From Intressa, Formerly Cardiatis) For The Treatment Of TAADs |
|
Presenter(s):Claude D. Vaislic, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 11:48 AM - 11:53 AM | Role Of Bare Metal AMDS Stents From Artivion (Formerly CryoLife/Jotec) For Repair Of Acute Type A Dissections: Indications And Results |
|
Presenter(s):Wilson Y. Szeto, MD / Grayson H. Wheatley, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 11:54 AM - 12:00 PM | Panel Discussion |
| 12:00 PM - 1:35 PM | Celebratory Lunch Break – Rhinelander Gallery, 2nd Floor Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 42 | |
| SESSION 43 SCHEDULE | |
|
Wednesday
SESSION 43:
MORE NEW DEVELOPMENTS IN AAA TREATMENT AND STANDARD EVAR: A NEW DEVICE TO SLOW AAA GROWTH; AAA NECK DILATATION AFTER EVAR; VALUE OF LOW PROFILE AAA ENDOGRAFTS; IMPROVED ULTRASOUND SURVEILLANCE AND ALL AAAs ARE NOT TIME BOMBS WAITING TO EXPLODE
|
|
| x | |
| 1:35 PM - 1:40 PM | Should Saccular AAAs Be Repaired At A Smaller Diameter Than Fusiform AAAs: How To Measure Saccular AAA Diameter: Should It Include The Normal Aorta Or Not |
|
Presenter(s):Frans L. Moll, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 1:41 PM - 1:46 PM | Decreasing Frequency Of Elective And Ruptured AAA Repairs Is Due To Epidemiology Rather Than Other Factors Like Screening |
|
Presenter(s):Ian Loftus, MD / Pete Holt, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| AAA NECK BEHAVIOR AFTER EVAR | |
| 1:47 PM - 1:52 PM | Optimal Stent Design And Optimal Degree Of Oversizing To Avoid Neck Dilatation And Why It Matters |
|
Presenter(s):Carlos F. Bechara, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 1:53 PM - 1:58 PM | Major Aortic Neck Dilatation Occurs Equally After EVAR And Open Repair: From The DREAM RCT: This ONLY Occurs After EVAR With Self-Expanding Endografts |
|
Presenter(s):Jan D. Blankensteijn, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 1:59 PM - 2:04 PM | What Should Be The Role Of Physician Modified Endografts (PMEGs) For the Treatment Of Short Or No Neck AAAs When Industry Made F/EVAR Devices Are Available: Why PMEGs Are Only Good In Some Centers: New Computer 3D Modeling Adjuncts (From Terumo) To Make PMEGs Better And Simpler |
|
Presenter(s):Benjamin W. Starnes, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 2:05 PM - 2:10 PM | DEBATE: Low Profile Devices For EVAR Are Failing: Their Future Is Questionable Based On Results Of Other Devices Like The Endurant Endograft At 10 Years (From The ENGAGE OUS Registry) |
|
Presenter(s):Hence J.M. Verhagen, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 2:11 PM - 2:16 PM | DEBATE: Not So: Ovation Stent-Grafts (From Endologix) Have Good 5-Year Results With No Neck Dilatation Or Migration Even With Challenging Neck Anatomy: Based On A Multicenter International Study Of A Low Profile Endograft |
|
Presenter(s):Mahmoud B. Malas, MD, MHS Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 2:17 PM - 2:22 PM | Is AAA Thrombus More Dangerous In Women Than In Men: What Are The Dangers Of Such Thrombus |
|
Presenter(s):Janet T. Powell, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 2:23 PM - 2:28 PM | How Well Does Non-Fluoroscopic Guidance Using The IOPS System From Centerline Work For Performance Of Standard EVAR: Findings From The MOTION Trial |
|
Presenter(s):Francis Caputo, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 2:29 PM - 2:34 PM | Despite Great Advances With AAA Management, Little Progress Has Been Made In 2 Important Areas: Improving Indications For Treatment And Precision Of Measurement: AAAs ≤6.0 cm Rarely Rupture |
|
Presenter(s):Frank J. Criado, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 2:35 PM - 2:41 PM | Panel Discussion |
| END OF SESSION 43 | |
| SESSION 44 SCHEDULE | |
|
Wednesday
SESSION 44:
MORE NEW DEVELOPMENTS IN AAAs: HOW DOES THROMBUS LOAD EFFECT PROGNOSIS AFTER EVAR AND EVAS; OTHER RELATED AAA TOPICS
Location: Trianon Ballroom, 3rd Floor
Moderators:Evan C. Lipsitz, MD, MBA / Janet T. Powell, MD, PhD |
|
| x | |
| AAA SAC THROMBUS LOAD | |
| 2:41 PM - 2:46 PM | Impact Of Thrombus In AAA Sac And Neck On AAA Behavior And EVAR Outcomes: How To Quantitate Thrombus Load And Distribution |
|
Presenter(s):Nicos Labropoulos, BSc (Med), PhD, DIC, RVT Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 2:47 PM - 2:52 PM | DEBATE: Large Amount Of AAA Sac Thrombus Promotes Morbidity Without Rupture And With Rupture: By What Mechanisms Is Thrombus Harmful And How Can Thrombus Load Be Quantitated |
|
Presenter(s):David H. Deaton, MD, FACS Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 2:53 PM - 2:58 PM | DEBATE: Large Flow Luminal Space In An AAA Sac With Minimal Mural Thrombus Is Associated With Adverse Events After EVAR: It Is More Important Than AAA Sac Size: Thrombus May Be Protective |
|
Presenter(s):Hence J.M. Verhagen, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| OTHER AAA RELATED TOPICS | |
| 2:59 PM - 3:04 PM | Graft Infolding: A Unique EVAR Complication: How To Prevent It And How To Treat It |
|
Presenter(s):Ashraf Mansour, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 3:05 PM - 3:10 PM | With Aneurysmal Disease What Causes The Aorta To Rotate: What Is The Impact Of Counterclockwise Rotation Of The Aneurysmal Aorta |
|
Presenter(s):Nicos Labropoulos, BSc (Med), PhD, DIC, RVT Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 3:11 PM - 3:16 PM | Observation For Small AAAs (<5.0 cm) Is Safe And Does Not Impair Future EVAR Options |
|
Presenter(s):Jon S. Matsumura, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 3:17 PM - 3:22 PM | Update On Median Arcuate Ligament Syndrome (MALS): Current Status Of Its Etiological Concepts And Optimal Diagnosis And Treatment |
|
Presenter(s):Prof. Dr. Med Wilhelm Sandmann, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 3:23 PM - 3:28 PM | Update On Technical Tips To Perform SAFE Large Sheath Percutaneous Femoral Access And Closure For Complex AAA EVAR In Obese Or Scarred Groins – Even With Calcified Arteries: It Is Almost Always Possible |
|
Presenter(s):Barend M.E. Mees, MD, PhD, FEBVS Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 3:29 PM - 3:34 PM | Increased Inflammatory Biomarkers And Increased 18F FDG Uptake On PET CT In AAA Patients Are Associated With Rapid Growth And Worse Long-Term Survival: Should These Markers Be Tested Routinely And How Should AAA Treatment Be Modified If They Are Elevated |
|
Presenter(s):Natzi Sakalihasan, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 3:35 PM - 3:41 PM | Panel Discussion |
| 3:41 PM - 3:50 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 44 | |
| SESSION 45 SCHEDULE | |
|
Wednesday
SESSION 45:
HOT AORTIC TOPICS
|
|
| x | |
| 3:50 PM - 3:55 PM | Aorto-Enteric Fistulas Associated With Infected EVARs Or Open Prosthetic Grafts; What Are The Differences Between Them And What Are the Implications For Treatment |
|
Presenter(s):Sal Scali, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 3:56 PM - 4:01 PM | International Experience With 1,000 Physician Modified Endografts For Complex Aortic Aneurysms: When Is The Procedure A Good Thing And When Is It A Bad Thing |
|
Presenter(s):Nikolaos Tsilimparis, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 4:02 PM - 4:07 PM | Impact Of COVID, The NICE Guidelines And Changing Disease Patterns On AAA Practice In The UK: Which Is Most Important |
|
Presenter(s):Ian Loftus, MD / Pete Holt, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 4:08 PM - 4:13 PM | TEVAR For Acute Complicated TBAD: Improved Outcomes When The Endograft Is Extended To Zone 2 Versus Zone 3: Why Is This So And What To Do About The Subclavian Artery |
|
Presenter(s):Jean M. Panneton, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 4:14 PM - 4:19 PM | Safe Anticoagulation In F/B/EVAR Patients Requiring Spinal Fluid Drainage |
|
Presenter(s):Afshin Assadian, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 4:20 PM - 4:25 PM | Panel Discussion |
| 4:25 PM - 4:30 PM | Are We Overtreating AAAs: The Current Diameter Threshold For AAA Repair Is No Longer Relevant: Based On New Scrutiny Of Old Trials And A Meta-Analysis Of AAA Rupture Risk |
|
Presenter(s):Timothy A. Resch, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 4:31 PM - 4:36 PM | What Is “Failure To Rescue” After Endovascular TAAA Repairs: What Factors Are Responsible And Why Is It Important |
|
Presenter(s):Jade S. Hiramoto, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 4:37 PM - 4:42 PM | Laser In Situ F/EVAR As An Off-The-Shelf Option For Ruptured Complex Or Short Necked AAAs And Failed EVAR: Experience And Technical Tips |
|
Presenter(s):Timothy A. Resch, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 4:43 PM - 4:48 PM Power Point Presentation with Synched Audio |
10-Year Experience Shows The Safety And Effectiveness Of Endoanchors For F/EVAR: They Support A Shortened Main Endograft Length And A Reduced Procedural Complexity |
|
Presenter(s):Jörg Tessarek, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 4:49 PM - 4:54 PM | Risk Factors And Late Clinical Consequences Of AAA Neck Dilatation After EVAR With Self-Expanding Endografts: What Are The Differences In Neck Behavior After Excluder And Endurant Endografts: Based On 10-Year Results From The ENGAGE Registry |
|
Presenter(s):Hence J.M. Verhagen, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 4:55 PM - 5:00 PM | Panel Discussion |
| END OF SESSION 45 | |
| SESSION 46 SCHEDULE | |
|
Wednesday
SESSION 46:
MORE SHORT HOT NEW TOPICS RELATED TO AORTO-ILIAC AND CAROTID DISEASE AND THEIR TREATMENTS; ANTI-ATHEROSCLEROSIS VACCINE
|
|
| x | |
| 5:01 PM - 5:06 PM | Are Low Profile Devices For EVAR And TEVAR Improving Or Worsening Outcomes |
|
Presenter(s):Naoki Fujimura, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 5:07 PM - 5:12 PM | Why Is It Important To Avoid “Lost To Follow Up” In AAA Studies: What Measures Can Do So |
|
Presenter(s):Matthew W. Mell, MD, MS Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 5:13 PM - 5:18 PM | Single Access Retrograde Iliac Branch Endograft Device (IBD) Implantation: Technique, Advantages And Limitations |
|
Presenter(s):Mario L. Lachat, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 5:19 PM - 5:24 PM | Treo Endograft From Terumo Aortic For EVAR: Advantages And 5-Year Results From The US IDE Trial |
|
Presenter(s):Michael C. Stoner, MD / Matthew J. Eagleton, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 5:25 PM - 5:30 PM | Isolated Iliac Artery Aneurysms Do NOT Rupture And Need To Be Treated Until They Are At Least 4 Centimeters In Diameter |
|
Presenter(s):Christopher J. Smolock, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 5:31 PM - 5:36 PM | How To Safely Stent The Large Fenestration Of A ZFEN Endograft When It Is Crossed By Struts: Indications For Doing So And Late Results |
|
Presenter(s):Luis A. Sanchez, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 5:37 PM - 5:42 PM | The Mega-Aortic Syndrome: What Is It: When And How Should It Be Treated |
|
Presenter(s):Martin Czerny, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 5:43 PM - 5:49 PM | Panel Discussion |
| CAROTID RELATED TOPICS | |
| 5:49 PM - 5:54 PM | Transcarotid Artery Revascularization (TCAR) Versus Carotid Endarterectomy (CEA): In A Single Center Experienced In Both, Which Is Best And When |
|
Presenter(s):Zach AbuRahma, DO / Ali F. AbuRahma, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 5:55 PM - 6:00 PM | Intracranial Angiography During TCAR: Technique And Value |
|
Presenter(s):Peter L. Faries, MD, FACS / Michael L. Marin, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| MORE AORTA RELATED TOPICS | |
| 6:01 PM - 6:06 PM | Improved Survival After Implementation Of A Large Scale Dedicated Network For Aortic Emergencies: Why The French SOS Aorta System Works |
|
Presenter(s):Jean-Marc Alsac, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 6:07 PM - 6:12 PM | How Can The Gore Recapturable C3 Excluder Endograft Be Modified As A PMEG For F/EVAR And TAAA Repair: Technique And Results |
|
Presenter(s):Wayne W. Zhang, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 6:13 PM - 6:18 PM | The Sandwich-Periscope Technique For Left Subclavian Revascularization With Zone 2 TEVAR: It May Be The Best Way And How To Do It: Technique |
|
Presenter(s):Sukgu Han, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| ANTI-ATHEROSCLEROSIS VACCINE | |
| 6:19 PM - 6:24 PM | An Interesting New Anti-Atherosclerosis Vaccine (AntheroVax): How It Works And Current Status |
|
Presenter(s):Nicholas Kipshidze, MD, PhD, DSc Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 6:25 PM - 6:30 PM | Panel Discussion End of Program F |
| END OF SESSION 46 | |